PanGen Biotech Inc (222110) — Capital Reinvestment Ratio
Latest as of June 2025:
0.02x
PanGen Biotech Inc (222110) has a Capital Reinvestment Ratio of 0.02x as of June 2025, meaning it reinvests 0% of its operating cash flow (₩3.22 Billion) in capital expenditures (₩56.30 Million). See 222110 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.02x
Capex / Operating Cash Flow
Operating Cash Flow
₩3.22 Billion
KRW
Capital Expenditures
₩56.30 Million
KRW
Data as of
Jun 2025
Most recent filing
PanGen Biotech Inc Capital Reinvestment Ratio (2024–2024)
This chart tracks PanGen Biotech Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for PanGen Biotech Inc (2024–2024)
Year-by-year Capital Reinvestment Ratio for PanGen Biotech Inc from 2024 to 2024. For live market cap and broader valuation context, see market value of PanGen Biotech Inc.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.13x | ₩2.99 Billion | ₩374.12 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow